You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 4,681,752


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,681,752
Title: Capsules containing the active principle of an allergen, and process for their preparation
Abstract:Capsules to be administered through an inhaler, or inhaler tube or nasal spray, containing a finely subdivided powder mixture of the active principle of one or more allergens, uniformly dispersed and incorporated into at least an excipient are described. The capsules have no bronchoconstrictive or irritating action on the nasal mucous membrane and are more effective than allergens administered in solution. The method of preparation is also described.
Inventor(s): Melillo; Gaetano (Naples, IT)
Assignee: Laboratorio Farmaceutico Lafarma S.a.S. (Milan, IT)
Application Number:06/597,241
Patent Claims:1. A telescoping two piece hard gelatine capsule perforated to emit powder through the holes, to be administered through insertion in an inhaler, inhaler tube or nasal spray, containing 40 mgs. per capsule of a finely subdivided freeze dry, anhydrous powder mixture whose particles are 90% smaller than 10 microns and the remainder 10% smaller than 20 microns of the active constituent of an allergen, which is a member selected from the group consisting of Dermatophagoides pteronyssinus, Dermatophagoides farinae, Ambrosia elatior, Agrostis maritima, Agrostis stolonifera, Poa pratensis, Dactylis glomerata, Holcus lamatus, Phleum pratense, Phalaris Canariensis, Lolium perenne, Lolium multiflorum, Festuca pratensis, Festuca ovina, Cynodon dactylon and Agarostis alba., said active constituent being uniformly dispersed into at least one lactose glucose or saccharose excipient having no brochoconstrictive or irritating action on the nasal mucous membrane in a ratio of excipient to allergen between 1:1 and 50,000:1.

2. A method of administration of an allergen to an individual who suffers from an allergy, which consists of administering to said individual a powder by emission through the holes of a perforated telescoping two piece hard gelatine capsule inserted in an inhaler or inhaler tube or nasal spray, said capsule containing 40 mgs. of a freeze dry, anhydrous powder which consists of a mixture whose particles are 90% smaller than 10 microns and the remainder 10% smaller than 20 microns of the active constituent of an allergen which is a member selected from the group consisting of Dermatophagoides pteronyssinus, Dermatophagoides farinae, Ambrosia elatior, Agrostis maritima, Agrostis stolonifera, Poa pratensis, Dactylis glomerata, Holcus lamatus, Phleum pratense, Phalaris canariensis, Lolium perenne, Lolium multiflorum, Festuca pratensis, Festuca ovina, Cynodon dactylon and Agrostis alba., said active constituent being uniformly dispensed in at least one lactose, glucose or saccharose excipient having no bronchoconstriction and irritation actions on the nasal mucous membrane, in a ratio of excipient to allergen between 1:1 and 50,000:1, said dry powder having a particle size lower than 50 microns.

3. The method according to claim 2 wherein the allergen is Dermotophagoides pteronyssinus.

4. The method according to claim 2, wherein the allergen is Dermatophagoides farinae.

5. The method according to claim 2, wherein the allergen is a Grass allergen or a mixture of Grass allergens.

6. The method according to claim 2, wherein the allergen is Ambrosia Elatior.

7. A capsule according to claim 1, wherein the quantity of the active constituent of said allergen in each capsule ranges from 1.8 millionth to 28 millionths of a gram.

Details for Patent 4,681,752

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Greer Laboratories, Inc. N/A insects (whole body), mite dermatophagoides farinae Injection 101834 09/15/1958 ⤷  Try a Trial 2004-07-21
Greer Laboratories, Inc. N/A insects (whole body), mite dermatophagoides pteronyssinus Injection 101835 09/15/1958 ⤷  Try a Trial 2004-07-21
Allermed Laboratories, Inc. N/A pollens - grasses, bermuda grass cynodon dactylon Injection 102214 06/14/1930 ⤷  Try a Trial 2004-07-21
Allermed Laboratories, Inc. N/A pollens - grasses, bluegrass, kentucky (june) poa pratensis Injection 102215 06/14/1930 ⤷  Try a Trial 2004-07-21
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.